<Record>
<Term>Iodine-131 Human Serum Albumin</Term>
<SemanticType>Pharmacologic Substance</SemanticType>
<ParentTerm>Radioimmunoconjugate</ParentTerm>
<ClassificationPath>Chemicals_and_Drugs_Kind/Drug, Food, Chemical or Biomedical Material/Pharmacologic Substance/Radiopharmaceutical Compound/Radioimmunoconjugate/Iodine-131 Human Serum Albumin</ClassificationPath>
<BroaderTerm>Radioimmunoconjugate</BroaderTerm>
<BroaderTerm>Radiopharmaceutical Compound</BroaderTerm>
<BroaderTerm>Chemicals_and_Drugs_Kind</BroaderTerm>
<BroaderTerm>Pharmacologic Substance</BroaderTerm>
<BroaderTerm>Iodine-131 Human Serum Albumin</BroaderTerm>
<BroaderTerm>Drug, Food, Chemical or Biomedical Material</BroaderTerm>
<Synonym>I 131 HSA</Synonym>
<Synonym>Iodine-131 Human Serum Albumin</Synonym>
<Description>A synthetic radiopharmaceutical in which human serum albumin (HSA) is radiolabelled with iodine 131.  Upon intravenous injection, iodine-131 human serum albumin is slowly deiodinated in vivo, releasing radioactive iodide that is taken up by thyroid gland.  Iodine-131 primarily emits beta particles and has a half-life of 8 days. (NCI04)</Description>
<Source>NCI Thesaurus</Source>
</Record>
